Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant718 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01503372 | FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer(PaFLO) | completed | Phase 2 | 75 | Charite University, Berlin, GermanyOTHER | 1 | Feb 12, 2019 | clinicaltrials |
| NCT01283204 | Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer | completed | Phase 2 | 180 | Yonsei UniversityOTHER | 1 | Jan 29, 2019 | clinicaltrials |
| NCT03350477 | Bioinformation Therapy for Gastric Cancer | completed | Phase 2 / Phase 3 | 120 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Jan 25, 2019 | clinicaltrials |
| NCT00215644 | Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric Cancer(MATRIX EG) | completed | Phase 2 | 72 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 4 | Nov 2, 2018 | clinicaltrials |
| NCT00137813 | Avastin and Taxotere for Esophagogastric Cancer | completed | Phase 2 | 42 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 1, 2018 | clinicaltrials |
| NCT00019474 | Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer | completed | Phase 2 | 60 | Montefiore Medical CenterOTHER | 1 | Sep 14, 2018 | clinicaltrials |
| NCT00607594 | Saracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction Cancer | completed | Phase 2 | 21 | National Cancer Institute (NCI)NIH | 2 | Aug 23, 2018 | clinicaltrials |
| NCT01461057 | A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer(JOSHUA) | completed | Phase 2 | 30 | Hoffmann-La RocheINDUSTRY | 8 | Aug 9, 2018 | clinicaltrials |
| NCT01783951 | Study of S-1 Plus DC-CIK for Patients With Advanced Gastric Cancer | completed | Phase 1 / Phase 2 | 63 | Capital Medical UniversityOTHER | 1 | Jul 19, 2018 | clinicaltrials |
| NCT00068380 | A Phase II Trial of STI571 in the Treatment of Metastatic Gastric Cancer | completed | Phase 2 | 17 | National Cancer Institute (NCI)NIH | 1 | Jul 11, 2018 | clinicaltrials |
| NCT01956149 | Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric Cancer | completed | Phase 2 | 65 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestOTHER | 1 | Apr 18, 2018 | clinicaltrials |
| NCT01757171 | Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma | completed | Phase 2 | 85 | Weill Medical College of Cornell UniversityOTHER | 1 | Apr 3, 2018 | clinicaltrials |
| NCT00938470 | Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | completed | Phase 2 | 73 | Alliance for Clinical Trials in OncologyOTHER | 1 | Mar 29, 2018 | clinicaltrials |
| NCT01822210 | Botulinum Toxin for Stomach Cancer Treatment | completed | Phase 2 | 7 | St. Olavs HospitalOTHER | 1 | Mar 9, 2018 | clinicaltrials |
| NCT00183872 | Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma | completed | Phase 2 | 40 | University of Southern CaliforniaOTHER | 1 | Feb 19, 2018 | clinicaltrials |
| NCT01612546 | Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery | completed | Phase 2 | 10 | City of Hope Medical CenterOTHER | 1 | Feb 1, 2018 | clinicaltrials |
| NCT01234324 | ECX + Panitumumab vs. ECX Alone in Locally Advanced Gastric Cancer or Cancer of the Gastroesophageal Junction(NEOPECX) | completed | Phase 2 | 171 | AIO-Studien-gGmbHOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT02015169 | Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis | completed | Phase 2 | 32 | Samsung Medical CenterOTHER | 1 | Jan 17, 2018 | clinicaltrials |
| NCT01178944 | Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer | completed | Phase 2 | 35 | Roswell Park Cancer InstituteOTHER | 1 | Dec 13, 2017 | clinicaltrials |
| NCT00201747 | Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer | completed | Phase 2 | 80 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Dec 6, 2017 | clinicaltrials |
| NCT00188266 | Study of Adjuvant Radiochemotherapy for Gastric Cancer | completed | Phase 1 / Phase 2 | 65 | University Health Network, TorontoOTHER | 1 | Sep 20, 2017 | clinicaltrials |
| NCT02527785 | Study of Oxaliplatin, Irinotecan, and S-1 in Gastric Cancer | completed | Phase 2 | 44 | Hallym University Medical CenterOTHER | 1 | Aug 23, 2017 | clinicaltrials |
| NCT00394433 | Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer | completed | Phase 2 | 38 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT02229058 | Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric Cancer | completed | Phase 2 | 73 | Sun Yat-sen UniversityOTHER | 1 | Jul 27, 2017 | clinicaltrials |
| NCT01921673 | Dovitinib Plus Docetaxel in Gastric Cancer | completed | Phase 1 / Phase 2 | 14 | Asan Medical CenterOTHER | 1 | Jul 14, 2017 | clinicaltrials |
| NCT00062374 | Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction | completed | Phase 2 | 55 | National Cancer Institute (NCI)NIH | 1 | Jul 6, 2017 | clinicaltrials |
| NCT01472029 | Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or Stomach(HerFLOT) | completed | Phase 2 | 53 | AIO-Studien-gGmbHOTHER | 1 | Jun 19, 2017 | clinicaltrials |
| NCT01231399 | Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer | completed | Phase 1 / Phase 2 | 6 | City of Hope Medical CenterOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT00376987 | Zinc Supplements in Lowering Cadmium Levels in Smokers | completed | Phase 2 | 61 | Wake Forest University Health SciencesOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00534001 | Bupropion in Helping Adults Stop Smoking | completed | Phase 2 | 95 | Roswell Park Cancer InstituteOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT01152645 | Study of ARQ 197 Monotherapy(ARQ 197-004) | completed | Phase 2 | 31 | Kyowa Kirin Co., Ltd.INDUSTRY | 2 | Mar 15, 2017 | clinicaltrials |
| NCT01576380 | A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients | completed | Phase 2 | 11 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 27, 2017 | clinicaltrials |
| NCT02890511 | A Study DHP107, a Novel Oral Paclitaxel Formulation, in Patients With Advanced Solid Tumours or Gastric Cancer | completed | Phase 1 / Phase 2 | 28 | Daehwa Pharmaceutical Co., Ltd.INDUSTRY | 1 | Feb 13, 2017 | clinicaltrials |
| NCT01441310 | Laparoscopic Sentinel Node Navigation Surgery for Gastric Cancer(SNNS) | completed | Phase 2 | 101 | Seoul National University Bundang HospitalOTHER | 1 | Jan 9, 2017 | clinicaltrials |
| NCT01441336 | Laparoscopic Gastrectomy for Advanced Gastric Cancer | completed | Phase 2 | 204 | Seoul National University Bundang HospitalOTHER | 1 | Jan 9, 2017 | clinicaltrials |
| NCT01938313 | Early Recovery After Surgery (ERAS) Versus Conventional Protocol After Laparoscopic Gastrectomy(ERAS) | completed | Phase 2 | 100 | Seoul National University Bundang HospitalOTHER | 1 | Jan 5, 2017 | clinicaltrials |
| NCT00054457 | Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction | completed | Phase 2 | 46 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 13, 2016 | clinicaltrials |
| NCT00022139 | Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | completed | Phase 2 | 56 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 7, 2016 | clinicaltrials |
| NCT00040859 | Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer | completed | Phase 2 | 48 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 7, 2016 | clinicaltrials |
| NCT00519324 | Efficacy and Safety of Everolimus (RAD001) in Patients With Advanced Gastric Cancer | completed | Phase 2 | 54 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 18, 2016 | clinicaltrials |
| NCT02004769 | Trastuzumab Plus Docetaxel and Capecitabine For First Line Treatment of Her2-Positive Advanced Gastric Cancer | completed | Phase 2 | 67 | Sun Yat-sen UniversityOTHER | 1 | Nov 18, 2016 | clinicaltrials |
| NCT00436241 | A Study of Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer. | completed | Phase 2 | 45 | Hoffmann-La RocheINDUSTRY | 1 | Nov 2, 2016 | clinicaltrials |
| NCT02903498 | The Maintenance Treatment of UFT in Advanced Gastric Cancer | completed | Phase 2 | 58 | Fudan UniversityOTHER | 0 | Oct 12, 2016 | clinicaltrials |
| NCT00454636 | A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer. | completed | Phase 2 | 158 | Hoffmann-La RocheINDUSTRY | 1 | Sep 29, 2016 | clinicaltrials |
| NCT01624025 | A Comparative Study of Salvage Treatment With Combination of Docetaxel and Epirubicin | completed | Phase 2 | 22 | Yonsei UniversityOTHER | 1 | Aug 17, 2016 | clinicaltrials |
| NCT01590719 | A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastroesophageal Cancer | completed | Phase 2 | 123 | Hoffmann-La RocheINDUSTRY | 6 | Aug 9, 2016 | clinicaltrials |
| NCT01953419 | Phase II Study of Pemetrexed in Advanced or Recurrent Gastric Cancer After Chemotherapy | completed | Phase 2 | 34 | Sun Yat-sen UniversityOTHER | 1 | Jul 28, 2016 | clinicaltrials |
| NCT00003137 | Irinotecan in Treating Patients With Advanced Cancer of the Stomach | completed | Phase 2 | 70 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 14, 2016 | clinicaltrials |
| NCT00004235 | Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach | completed | Phase 2 | 47 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 14, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Feb 12, 2019source: clinicaltrials